Article Details

StartUp Health Insights: NEXT Life Sciences Secures $2.5M for 'Plan A' Male Birth Control

Retrieved on: 2024-01-23 17:51:58

Tags for this article:

Click the tags to see associated articles and topics

StartUp Health Insights: NEXT Life Sciences Secures $2.5M for 'Plan A' Male Birth Control. View article details on hiswai:

Summary

The article discusses the venture capital funding of NEXT Life Sciences and its male contraceptive product Plan A™, highlighting a broader context in private equity, entrepreneurship, and startup health within corporate and capital management frameworks.

Article found on: healthtransformer.co

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up